Aytu BioPharma Inc

+0.04 (+1.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)16.09M
Current PEN/A
Forward PE N/A
2yr Forward PE 3.7
See more stats
Estimates Current Quarter
Revenue$18.3 Million
Adjusted EPS-$0.45
See more estimates
10-Day MA$2.93
50-Day MA$3.01
200-Day MA$2.77
See more pivots

Aytu BioPharma Inc Stock, NASDAQ:AYTU

7900 East Union Avenue, Suite 920, Englewood, Colorado 80237
United States of America
Phone: +1.720.437.6580
Number of Employees: 150


Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.